PATH UiPath

Research status: Primary-source verified through Q2 FY2027 results on 3 September 2026. Current market reference: $15.19 close on 4 September 2026.

UiPath's Q2 was a constructive but not thesis-changing print. Revenue was $410M, +13% YoY, and ARR reached $1.938B, +12% YoY, with $37M net-new ARR and dollar-based net retention of 109%. GAAP operating income was $32M, non-GAAP operating income $89M, operating cash flow $31M, adjusted FCF $31M, and cash/securities were $1.405B.

Management raised the full-year framework to $1.789–1.794B revenue, $2.065–2.070B ARR, and about $445M non-GAAP operating income. Q3 guidance is $440–445M revenue, $1.992–1.997B ARR and about $100M non-GAAP operating income. This confirms disciplined execution and durable profitability, while Maestro/Maestro Flow and agentic-orchestration positioning continue to broaden the strategic narrative.

The unresolved question remains growth quality. NRR is still 109% rather than reaccelerating above 110–115%, and Q2 net-new ARR of $37M is below the prior preferred >$45–50M quarterly zone. At $15.19, valuation is more forgiving than at the prior review, but the stock should not be promoted solely because it is cheap. Current conclusion: keep PATH at investigate/watch; the thesis strengthened modestly on guidance/profitability, but a buy case still needs clearer proof that agentic products improve expansion/retention and that ARR growth can sustainably reaccelerate.

UiPath's investment case is that enterprises need a neutral, governed orchestration layer spanning AI agents, deterministic robots, APIs, documents, systems and people. Q2 FY2027 supports the durability of the installed base and the improving financial model, but it has not yet proven that agentic products are materially accelerating expansion. The moat should be judged by NRR, net-new ARR, large-customer cohorts, production adoption and durable GAAP/FCF economics—not feature launches alone.

Q3 revenue/ARR above guidance; NRR moving above 110–115%; net-new ARR reacceleration; measurable Maestro/agentic production adoption and expansion; growth in >$100K and >$1M ARR cohorts; WorkFusion cross-sell; sustained GAAP operating profitability and lower SBC intensity.

Microsoft bundling; ServiceNow/Salesforce/platform competition; agent commoditization; NRR stuck near ~109% or lower; weak new-logo growth; SBC and GAAP/non-GAAP gap; WorkFusion integration risk; founder control; narrative outrunning measurable ARR contribution.

Warning — freeze additions and investigate

• Q2 ARR below $1.929B or FY2027 ARR guide below $2.058B.
• Dollar-based NRR below 105% for two consecutive quarters.
• Net-new ARR below $40M for two quarters.
• >$100K ARR customers flat/down for two quarters.
• GAAP operating margin turns negative again while SBC exceeds ~15% of revenue.
• Agentic/Maestro production evidence remains anecdotal after multiple quarters.

Reduce

• ARR growth falls below 10% for two quarters with no reacceleration evidence.
• Net retention falls to ~100% or below.
• Operating cash flow less capex trends below $300M annualized while growth remains low-teens or worse.
• Microsoft/ServiceNow displacement becomes visible in renewal or win/loss data.
• WorkFusion/agentic investments increase opex without measurable expansion ARR.

Invalidate

> Invalidate if UiPath fails to convert its installed automation base into an agentic-orchestration moat—specifically, ARR growth falls to high single digits or lower, NRR approaches 100%, and Maestro/agentic products do not create measurable retention/expansion while GAAP profitability weakens.

Additional hard invalidators: material customer migration to bundled alternatives, sustained share-count expansion despite buybacks, or a structural loss of cross-platform relevance.

UiPath's best position is not 'best AI agent.' It is governed cross-application execution.

• Microsoft: largest structural threat because Power Automate/Copilot are bundled into an enormous enterprise footprint. UiPath must win where workflows span non-Microsoft systems, legacy applications and regulated controls.
• ServiceNow / Salesforce: strong inside their own workflow/data domains but less neutral across the enterprise estate.
• Automation Anywhere: direct RPA/agentic automation competitor.
• AI-native computer-use agents: potentially disruptive at the task layer, but can also increase demand for orchestration, controls and auditability.

UiPath's potential moat is the installed automation base, process knowledge, governance, observability and ability to coordinate deterministic + probabilistic execution. The key evidence is not feature announcements; it is higher NRR, larger cohorts and durable production usage.

1. Track Q3 revenue versus $440–445M and ARR versus $1.992–1.997B.
2. Require quantitative evidence on Maestro/agentic production customers, ARR contribution, renewal and expansion—not only launch activity.
3. Track net-new ARR and NRR; treat sustained NRR >110–115% and net-new ARR >$45–50M as stronger evidence of reacceleration.
4. Track >$100K and >$1M ARR cohorts and new-logo contribution.
5. Reconcile GAAP operating income/FCF with SBC, buybacks and diluted share count.
6. Separate organic ARR growth from acquisitions/FX and track WorkFusion cross-sell economics.
7. Compare PATH with other Robotics-AI/software opportunities before any buy plan; lower valuation alone is insufficient.
8. Re-underwrite after Q3 FY2027 results or earlier if management provides material quantitative agentic-adoption data.